California Trim Clinic says todays questions are becoming more medically complex
3 In the Phase 3 ATTAIN-1 trial, orforglipron at the highest dose (36 mg) produced an average weight loss of 11.2% over 72 weeks in adults with obesity
Your GI system built tolerance progressively
The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript
SCFA and metabolic-support strains Bacillus subtilis is a spore-forming strain that survives stomach acid to reach the intestine intact, where it supports short-chain fatty acid production, the same butyrate-and-propionate pathway that stimulates natural GLP-1 release
Another clinician on the call reported a similar case from that same day: a 42-year-old woman with AUD, anxiety, and depression, seven weeks into tirzepatide